Mathematical Biosciences and Engineering (MBE)

Development of a computational model of glucose toxicity in the progression of diabetes mellitus
Pages: 1043 - 1058, Issue 5, October 2016

doi:10.3934/mbe.2016029      Abstract        References        Full text (2312.9K)           Related Articles

Danilo T. Pérez-Rivera - Department of Chemistry, University of Puerto Rico at Cayey, Cayey, PR 00736-9997, United States (email)
Verónica L. Torres-Torres - Department of Natural Sciences, University of Puerto Rico at Cayey, Cayey, PR 00736-9997, United States (email)
Abraham E. Torres-Colón - Department of Natural Sciences, University of Puerto Rico at Cayey, Cayey, PR 00736-9997, United States (email)
Mayteé Cruz-Aponte - Department of Mathematics - Physics, University of Puerto Rico at Cayey, Cayey, PR 00736-9997, United States (email)

1 Statistics about diabetes: American diabetes association, http://www.diabetes.org/diabetes-basics/statistics/, Accessed: 2014-04-03.
2 V. Åberg, A. Thörne, A. Alvestrand and J. Nordenström, Combined hypertriglyceridemic and insulin-glucose clamps for the characterization of substrate oxidation and plasma elimination of a long-chain triglyceride emulsion in healthy men, Metabolism, 61 (2012), 221-228.
3 J. M. Berg, J. L. Tymoczko and L. Stryer, Biochemistry, 5th edition, 2002.
4 J. M. Berg, J. L. Tymoczko and L. Stryer, Glycogen breakdown and synthesis are reciprocally regulated, in Biochemistry, 5th edition, Section 21.5, W H Freeman, New York, 2002.
5 R. N. Bergman, L. S. Phillips and C. Cobelli, Physiologic evaluation of factors controlling glucose tolerance in man: Measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose, Journal of Clinical Investigation, 68 (1981), 1456-1467.
6 M. J. Birnbaum, Turning down insulin signaling, Journal of Clinical Investigation, 108 (2001), 655-659.
7 M. Bollen, S. Keppens and W. Stalmans, Specific features of glycogen metabolism in the liver, Biochem. J, 15 (1998), 19-31.
8 L. Bouwens and I. Rooman, Regulation of pancreatic beta-cell mass, Physiological reviews, 85 (2005), 1255-1270.
9 A. E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R. A. Rizza and P. C. Butler, $\beta$-cell deficit and increased $\beta$-cell apoptosis in humans with type 2 diabetes, Diabetes, 52 (2003), 102-110.
10 M. R. Castro, Is hyperinsulinemia a form of diabetes?, http://www.mayoclinic.org/diseases-conditions/type-2-diabetes/expert-answers/hyperinsulinemia/faq-20058488, Accessed: 2014-04-03.
11 C. M. Elks, N. Mariappan, M. Haque, A. Guggilam, D. S. Majid and J. Francis, Chronic nf-$\kappa$b blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in shr, American Journal of Physiology-Renal Physiology, 296 (2009), F298-F305.
12 M. Elks, Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release., Endocrinology, 133 (1993), 208-214.
13 P. Felig and J. Wahren, Influence of endogenous insulin secretion on splanchnic glucose and amino acid metabolism in man, Journal of Clinical Investigation, 50 (1971), 1702-1711.
14 J. E. Gerich, The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity, Endocrine reviews, 19 (1998), 491-503.
15 S. Gremlich, C. Bonny, G. Waeber and B. Thorens, Fatty acids decrease idx-1 expression in rat pancreatic islets and reduce glut2, glucokinase, insulin, and somatostatin levels, Journal of Biological Chemistry, 272 (1997), 30261-30269.
16 M. J. Haller, M. A. Atkinson and D. Schatz, Type 1 diabetes mellitus: Etiology, presentation, and management, Pediatric Clinics of North America, 52 (2005), 1553-1578.
17 M.-T. Huang and R. L. Veech, Role of the direct and indirect pathways for glycogen synthesis in rat liver in the postprandial state, Journal of Clinical Investigation, 81 (1988), 872-878.
18 R. Lupi and S. Del Prato, $\beta$-cell apoptosis in type 2 diabetes: Quantitative and functional consequences, Diabetes & metabolism, 34 (2008), S56-S64.
19 A. Makroglou, J. Li and Y. Kuang, Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: An overview, Applied numerical mathematics, 56 (2006), 559-573.       
20 T. M. Mason, T. Goh, V. Tchipashvili, H. Sandhu, N. Gupta, G. F. Lewis and A. Giacca, Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats, Diabetes, 48 (1999), 524-530.
21 D. Mellitus, Diagnosis and classification of diabetes mellitus, Diabetes care, 28 (2005), S37.
22 S. Y. Morris, How insulin and glucagon work, http://www.healthline.com/health/diabetes/insulin-and-glucagon#Overview1, Accessed: 2014-04-03.
23 R. Murray, D. Bender, K. M. Botham, P. J. Kennelly, V. Rodwell and P. A. Weil, Harpers Illustrated Biochemistry 29/E, McGraw Hill Professional, 2012.
24 J. M. Olefsky, Pathogenesis of insulin resistance and hyperglycemia in non-insulin-dependent diabetes mellitus, The American Journal of Medicine, 79 (1985), 1-7.
25 G. Paolisso, A. Gambardella, L. Amato, R. Tortoriello, A. d'Amore, M. Varricchio and F. d'Onofrio, Opposite effects of short-and long-term fatty acid infusion on insulin secretion in healthy subjects, Diabetologia, 38 (1995), 1295-1299.
26 K. F. Petersen and G. I. Shulman, Etiology of insulin resistance, The American journal of medicine, 119 (2006), S10-S16.
27 V. Poitout and R. P. Robertson, Minireview: secondary $\beta$-cell failure in type 2 diabetes?a convergence of glucotoxicity and lipotoxicity, Endocrinology, 143 (2002), 339-342.
28 K. Polonsky, B. Given, L. Hirsch, E. Shapiro, H. Tillil, C. Beebe, J. Galloway, B. Frank, T. Karrison and E. Van Cauter, Quantitative study of insulin secretion and clearance in normal and obese subjects, Journal of Clinical Investigation, 81 (1988), 435-441.
29 G. M. Reaven, Role of insulin resistance in human disease, Role of Insulin Resistance in Human Disease, 1 (1992), 91-97.
30 J. Reece, L. A. Urry, N. Meyers, M. L. Cain, S. A. Wasserman, P. V. Minorsky, R. B. Jackson and B. N. Cooke, Campbell Biology, Pearson Higher Education AU, 2011.
31 R. P. Robertson, J. Harmon, P. O. Tran, Y. Tanaka and H. Takahashi, Glucose toxicity in $\beta$-cells: Type 2 diabetes, good radicals gone bad, and the glutathione connection, Diabetes, 52 (2003), 581-587.
32 R. P. Robertson, J. Harmon, P. O. T. Tran and V. Poitout, $\beta$-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes, Diabetes, 53 (2004), S119-S124.
33 R. P. Robertson, L. K. Olson and H.-J. Zhang, Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene, Diabetes, 43 (1994), 1085-1089.
34 S. Robin, Expected blood glucose after a high carb meal, http://healthyeating.sfgate.com/expected-blood-glucose-after-highcarb-meal-3529.html, Accessed: 2014-04-03.
35 J. Ruhl, How blood sugar control works-and how it stops working, http://www.phlaunt.com/diabetes/14046621.php, Accessed: 2014-04-03.
36 Y. SAKO and V. E. GRILL, A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and b cell oxidation through a process likely coupled to fatty acid oxidation*, Endocrinology, 127 (1990), 1580-1589.
37 G. Scheiner, Strike the spike ii." diabetes self-managment, http://www.diabetesselfmanagement.com/managing-diabetes/blood-glucose-management/strike-the-spike-ii/, Accessed: 2014-04-03.
38 O. Shaham, R. Wei, T. J. Wang, C. Ricciardi, G. D. Lewis, R. S. Vasan, S. A. Carr, R. Thadhani, R. E. Gerszten and V. K. Mootha, Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity, Molecular Systems Biology, 4 (2008), p214.
39 M. C. Stoppler, Hyperglycemia: Facts on symptom, signs and treatment, http://www.medicinenet.com/hyperglycemia/article.htm, Accessed: 2014-04-03.
40 M. Stumvoll, A. Mitrakou, W. Pimenta, T. Jenssen, H. Yki-Järvinen, T. Van Haeften, W. Renn and J. Gerich, Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity, Diabetes care, 23 (2000), 295-301.
41 O. Tanner, Intensive versus conventional glucose control in critically ill patients, Journal of the Intensive Care Society, 10 (2009), 216-217.
42 B. Topp, K. Promislow, G. Devries, R. M. Miura and D. T FINEGOOD, A model of $\beta$-cell mass, insulin, and glucose kinetics: Pathways to diabetes, Journal of Theoretical Biology, 206 (2000), 605-619.
43 Y.-F. Wang, M. Khan and H. A. van den Berg, Interaction of fast and slow dynamics in endocrine control systems with an application to $\beta$-cell dynamics, Mathematical biosciences, 235 (2012), 8-18.       
44 G. C. Weir and S. Bonner-Weir, Five stages of evolving beta-cell dysfunction during progression to diabetes, Diabetes, 53 (2004), S16-S21.
45 L. Wu, W. Nicholson, S. M. Knobel, R. J. Steffner, J. M. May, D. W. Piston and A. C. Powers, Oxidative stress is a mediator of glucose toxicity in insulin-secreting pancreatic islet cell lines, Journal of Biological Chemistry, 279 (2004), 12126-12134.
46 Y.-P. Zhou and V. E. Grill, Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle, Journal of Clinical Investigation, 93 (1994), 870-876.

Go to top